Heparin Hearing on Capitol Hill Turns Feisty

The head of the Food and Drug Administration Andrew von Eschenbach testifies before a House subcommittee about planned improvements to oversee the foreign manufacture of drug ingredients. The hearing comes after tainted batches of the blood thinner Heparin were linked to a dozen Chinese companies.

Marcia Crosse, a health care director for the Government Accountability Office who testified at the hearing, talks with Melissa Block about how much it would cost to inspect foreign drug plants.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.